Literature DB >> 12806219

Effects of fructose on hepatic glucose metabolism.

Owen P McGuinness1, Alan D Cherrington.   

Abstract

PURPOSE OF REVIEW: The liver plays an important role in glucose tolerance. A number of studies have suggested fructose improves glucose tolerance especially in insulin resistant settings. This review summarizes the recent work suggesting that fructose enhances glucose tolerance by augmenting liver glucose uptake. This increase may be mediated by the translocation and activation of hepatic glucokinase. RECENT
FINDINGS: Catalytic quantities of fructose (<10% of total carbohydrate flux) enhance liver glucose uptake in a dose dependent manner. The primary fate of the glucose is glycogen synthesis. The ability of fructose to augment liver glucose uptake is not impaired by the presence of marked insulin resistance such as in type 2 diabetes or infection. In addition, it is able to further enhance liver glucose uptake in the normal adapted setting of total parenteral nutrition and reverse the infected-induced decrease in liver glucose uptake. Studies also demonstrate that the beneficial effects of fructose on liver glucose uptake during chronic nutritional support do not persist.
SUMMARY: Fructose is a potent acute regulator of liver glucose uptake and glycogen synthesis. Inclusion of catalytic quantities of fructose in a carbohydrate meal improves glucose tolerance. This improvement is primarily mediated by the activation of hepatic glucokinase and consequent facilitation of liver glucose uptake. The improvement in glucose tolerance is most evident in insulin resistant settings (e.g. Type 2 diabetes and infection). The beneficial effect of fructose on hepatic glucose disposal, however, does not persist if fructose is given continuously such as in total parenteral nutrition.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12806219     DOI: 10.1097/01.mco.0000078990.96795.cd

Source DB:  PubMed          Journal:  Curr Opin Clin Nutr Metab Care        ISSN: 1363-1950            Impact factor:   4.294


  21 in total

1.  Diverse roles for the Drosophila fructose sensor Gr43a.

Authors:  Tetsuya Miyamoto; Hubert Amrein
Journal:  Fly (Austin)       Date:  2013-11-22       Impact factor: 2.160

Review 2.  Fructose Metabolism from a Functional Perspective: Implications for Athletes.

Authors:  Luc Tappy; Robin Rosset
Journal:  Sports Med       Date:  2017-03       Impact factor: 11.136

Review 3.  Pathway-selective insulin resistance and metabolic disease: the importance of nutrient flux.

Authors:  Yolanda F Otero; John M Stafford; Owen P McGuinness
Journal:  J Biol Chem       Date:  2014-07-25       Impact factor: 5.157

4.  Probiotic Lactobacillus casei Zhang ameliorates high-fructose-induced impaired glucose tolerance in hyperinsulinemia rats.

Authors:  Yong Zhang; Lifeng Wang; Jiachao Zhang; Yunxu Li; Qiuwen He; He Li; Xiao Guo; Jianlin Guo; Heping Zhang
Journal:  Eur J Nutr       Date:  2014-02       Impact factor: 5.614

5.  Continuous low-dose fructose infusion does not reverse glucagon-mediated decrease in hepatic glucose utilization.

Authors:  Paulette M Johnson; Sheng-Song Chen; Tammy S Santomango; Phillip E Williams; D Brooks Lacy; Owen P McGuinness
Journal:  Metabolism       Date:  2010-10-12       Impact factor: 8.694

Review 6.  Fructose metabolism and metabolic disease.

Authors:  Sarah A Hannou; Danielle E Haslam; Nicola M McKeown; Mark A Herman
Journal:  J Clin Invest       Date:  2018-02-01       Impact factor: 14.808

Review 7.  The use of carbohydrates during exercise as an ergogenic aid.

Authors:  Naomi M Cermak; Luc J C van Loon
Journal:  Sports Med       Date:  2013-11       Impact factor: 11.136

8.  Fructose, insulin resistance, and metabolic dyslipidemia.

Authors:  Heather Basciano; Lisa Federico; Khosrow Adeli
Journal:  Nutr Metab (Lond)       Date:  2005-02-21       Impact factor: 4.169

9.  Effect of pioglitazone on the fructose-induced abdominal adipose tissue dysfunction.

Authors:  Ana Alzamendi; Andrés Giovambattista; María E García; Oscar R Rebolledo; Juan J Gagliardino; Eduardo Spinedi
Journal:  PPAR Res       Date:  2012-10-02       Impact factor: 4.964

10.  Fructose: a key factor in the development of metabolic syndrome and hypertension.

Authors:  Zeid Khitan; Dong Hyun Kim
Journal:  J Nutr Metab       Date:  2013-05-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.